Concert Pharmaceuticals Completes Enrollment of 12 mg Cohort in Phase 2a Trial Life Science Investing
Aurinia Announces Voclosporin Ophthalmic Solution Demonstrates Statistically Superior Efficacy Versus Restasis Life Science Investing
TRACON Pharmaceuticals Announces Positive Data from Ongoing Phase 1b/2 Trial of TRC105 Life Science Investing
MediciNova Receives Notice of Allowance for New Patent Covering the Combination of MN-166 Pharmaceutical Investing
Antibe Therapeutics Receives Approval to Initiate Part Two of Phase 2B Dose-Ranging, Efficacy Study for ATB-346 Life Science Investing
